Business Plan

Confidential Presentation

Overview

Earthwise Nutraceuticals is raising $2.5m to establish a 35,000 sq ft outsourced contract manufacturing organization (CMO) for wellness brands producing natural supplement products — tablets, capsules, powders, and liquids.

We specialize in plant-based, clean-label formulations aligned with rising consumer demand for natural health products.

Financial Highlights

Total Raise: $2.5M


$8M

Year 1 Revenue

Increasing to $26.8M in Yr 5

50%

Gross Margin

Strong unit economics

30%

EBITDA Margin

Healthy profitability

6mo

To Breakeven

Short runway to profit

$1.25m

Closing Cash Yr 1

excl add'l investment

6.2x

Strong DSCR

Debt service coverage ratio

Being Driven by Operators with Decades of Experience

The Problem

Supply Chain Instability

Offshore dependence creates unreliable delivery and quality control issues.

Limited Clean-Label Options

Lack of affordable U.S. manufacturing for natural, transparent formulations.

High Barriers to Entry

Major CMOs require high MOQs and long lead times, blocking emerging brands.

Trust Gap

Low confidence in ingredient quality and transparency from offshore suppliers.

Our Solution

GMP-Compliant Facility

Fully equipped U.S. manufacturing meeting highest quality standards.

Rapid Turnaround

1–2 weeks development, 4 weeks reorders — industry-leading speed.

Smaller MOQs

Brand flexibility with accessible minimum order quantities.

End-to-End Production

Complete service: sourcing, compounding, packaging, fulfillment.

Traction & Pipeline

9

Immediate Clients

Waiting to place orders, representing ~$18M revenue

40+

Sales Relationships

Existing long-standing relationships worth $50M+ in potential annual revenue

$1.1M

Monthly Throughput

Expected immediate ramp-up capacity per month

Contingent Customers

(Values based on existing actual order levels of these specific customers. Soft commitments received, contingent on GMP-compliant factory setup and AR terms.)

Market Opportunity

$130.5B

2034 Market Size

U.S. Nutraceutical CMO market projected growth

12.3%

CAGR

Compound annual growth rate through 2034

$22.8B

SAM

Supplement CMO sub-sector serviceable market



  • Clean-label, cognitive health, and natural trends expanding faster than traditional VMS categories.
  • E-commerce and private-label explosion fueling small-batch production demand.

Business Model

Manufacturing Contracts

Core recurring B2B CMO revenue stream

Formulation Consulting

Expert guidance for custom product development

White-Label Development

Complete product solutions for brands

Future DTC Brand

Direct consumer product line expansion

Competitive Advantages

1

Local Manufacturing

U.S.-based operations ensure supply chain reliability, consistent pricing, and faster turnaround.

2

Comprehensive CMO Services

Full production spectrum — powders, tablets, capsules, softgels, liquids — with packaging for premium and value-tier products.

3

Custom Formulation Expertise

In-house experts co-create new formulations for niche markets, driving higher margins and customer loyalty.

4

Smaller MOQs

Capture emerging brands and fast-growth niches often ignored by large CMOs.

5

Quality Sourcing at Affordable Prices

Trusted suppliers across U.S., Canada, Mexico, New Zealand, and Australia enable transparency and premium quality without inflating cost.

Operations & Tampa Bay Facility

35,000 sq ft GMP-compliant manufacturing center

Climate-Controlled Production Zones

  • Pharmacy
  • Blending
  • Encapsulation
  • Liquids
  • Packaging

Capacity to handle 2x volume with upgrades


Sachets

Tablets

Capsules

Liquids

Powders

Combination Packs

Team & Advisors

Ted Jackson, CEO

37 years nutraceutical/pharma management experience. Developed 1,500+ formulations. (link)

Osmel Martinez, COO

30 years pharma manufacturing operations. GMP compliance specialist.

Dave Amelin, Sales Director

30 years fitness & nutraceutical sales. Large existing client network. (link)

Stephen Lieberman, Advisor

Former FDA official. Regulatory attorney & quality expert.

Funder Opportunity

Early Entry

$2.5M raise into an undervalued, asset-backed CMO with proven demand.

Fast Growth

Recurring B2B revenues with 50%+ gross margins and scalable operations.

Exit Potential

Strategic acquisition or equity buyout within 5–7 years.

Target Returns

12-20% based on conservative growth model and market dynamics.

Uses of Capital

Total Capital Raise:

$2,500,000

Strategic allocation across equipment, facility preparation, and operational runway to ensure successful launch and scale.

Use of Capital Timeline

1

Setup (mo 0)

Equip Purchase - $780k

*(Equip det in next slide)

Prof & Closing - $55k

TOTAL - $835k

2

Start Ops (mo 1-3)

Opex Runway - $317k

(Fixed exp, Variable exp, Salaries, etc)

Facility Buildout - $580k

TOTAL - $897k

3

Start Manuf. (mo 4)

Opex Runway - $89k

Purchase Inventory - $130k

TOTAL - $219k

4

Start Sales (mo 5-7)

Working Capital - $264k

Purchase Inventory - $130k

TOTAL - $394k

Contingency Fund - $154k




TOTAL

$2.5m

Equipment & FFE Details

Profit & Loss - 5 Yrs to 2030

Balance Sheet - 5 Yrs to 2030

For a copy of the detailed business plan, click below:

Click here

📞 Contact

Ted Jackson

ewn.finance@gmail.com

📞 Contact

Henry Land

hl@trajectory.financial

🟢 Prepared By

Henry Land

Made with